

ETHYL (2-MERCAPTOBENZOATO-S) MERCURY, SODIUM SALT; SODIUM ETHYLMERCURITHIOSALICYLATE; SODIUM SALT ETHYL (2-MERCAPTOBENZOATO-S) MERCURY; THIOMERSAL; ( (O-CARBOXYPHENYL) THIO) ETHYLMERCURY SODIUM SALT; ELICIDE; ETHYL (SODIUM O-MERCAPTOBENZOATO) MERCURY; ETHYL (2-MERCAPTOBENZOATO-S) MERCURY SODIUM SALT; ETHYLMERCURITHIOSALICYLIC ACID SODIUM SALT; ETHYLMERKURITHIOSALICILAN SODNY (CZECH) ; MERCUROTHIOLATE


Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to this ingredient -- not the products containing it -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
| This ingredient: | |
![]() | Cancer |
![]() | Developmental/reproductive toxicity |
![]() | Violations, restrictions & warnings |
![]() | Allergies/immunotoxicity |
![]() | Contamination concerns |
![]() | Other strong concerns for this ingredient: Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
![]() | Other moderate concerns for this ingredient: Neurotoxicity, Endocrine disruption, Irritation (skin, eyes, or lungs), Biochemical or cellular level changes |
![]() | Lesser or emerging concerns for this ingredient: Ecotoxicology, Data gaps |
|
See products containing THIMEROSAL | |
About THIMEROSAL: Thimerosal is a mercury-based preservative used in some vaccines and cosmetics. According to FDA, 'Mercury compounds are readily absorbed through the skin on topical application and tend to accumulate in the body. They may cause allergic reactions, skin irritation, or neurotoxic manifestations.' Mercury is considered particularly toxic to the developing brain during pregnancy, infancy and childhood. FDA has banned the use of mercury compounds in all cosmetics except those used around the eyes, w ... read more
THIMEROSAL has reported used in the following product types: mascara (2); eye shadow (1)
| type of concern | product conditions | reference |
| Known human immune system toxicant | National Library of Medicine HazMap | |
| Human skin toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Limited evidence of immune system toxicity | A Relational Database of Hazardous Chemicals and Occupational Diseases, 1987 | |
| Human immune toxicant - moderate evidence | CHE Toxicant and Disease Database |
| type of concern | product conditions | reference |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | Canada - Prohibited and Restricted Cosmetics Ingredients | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Restricted for use in cosmetics by the FDA (US) | U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Use is restricted in Canadian cosmetics | Canada - Prohibited and Restricted Cosmetics Ingredients | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Restricted in EU cosmetics (mandatory manufacturing or structural specifications) | European Union - Banned or Restricted in Cosmetics |
| type of concern | product conditions | reference |
| Possible human developmental toxicant | California EPA Proposition 65 | |
| Human nervous system toxicant - strong evidence | CHE Toxicant and Disease Database | |
| Human developmental toxicant - strong evidence | Proposition 65 List of Carcinogens | |
| Limited evidence of reproductive toxicity | European Union - Classification & Labelling | |
| Limited evidence of reproductive toxicity | National Library of Medicine HazMap | |
| Limited evidence of toxicity | National Academy - Institute of Medicine, 2004 | |
| Human reproductive toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human developmental toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human musculoskeletal toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - moderate evidence | CHE Toxicant and Disease Database | |
| Human nervous system toxicant - moderate evidence | Chemicals known to be neurotoxic to humans | |
| One or more animal studies show reproductive effects at very low doses | RTECS®- Rinsho Ganka 1972 | |
| show more | ||
| type of concern | product conditions | reference |
| Strong evidence of human neurotoxicity | CHE Toxicant and Disease Database | |
| Strong evidence of human neurotoxicity | Chemicals known to be neurotoxic to humans | |
| Limited evidence of toxicity | National Academy - Institute of Medicine, 2004 | |
| One or more animal studies show brain and nervous system effects at very low doses | RTECS®- Toxicologist | |
| show more | ||
| type of concern | product conditions | reference |
| Known human respiratory toxicant | EPA Hazardous Air Pollutants | |
| Known human renal toxicant | CHE Toxicant and Disease Database | |
| Known human respiratory toxicant | products that may be aerosolized (airborne) | CHE Toxicant and Disease Database |
| Known human sense organ toxicant | CHE Toxicant and Disease Database | |
| Possible human hematologic toxicant | CHE Toxicant and Disease Database | |
| Possible human renal toxicant | CHE Toxicant and Disease Database | |
| Possible human cardiovascular toxicant | CHE Toxicant and Disease Database | |
| Possible human respiratory toxicant | CHE Toxicant and Disease Database | |
| One or more animal studies show blood effects at very low doses | RTECS®- Toxicologist | |
| One or more animal studies show metabolic effects at very low doses | RTECS®- Toxicologist | |
| Classified as expected to be toxic or harmful | Environmental Canada Domestic Substance List | |
| show more | ||
| type of concern | product conditions | reference |
| Persistent, bioaccumulative in wildlife and humans | National Library of Medicine HazMap | |
| Persistent, bioaccumulative in wildlife and humans | EPA Toxic Release Inventory PBTs | |
| Persistent, bioaccumulative in wildlife | National Library of Medicine HazMap | |
| Persistent, bioaccumulative in wildlife | Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | |
| Persistent, bioaccumulative in wildlife | Great Lakes BTS (Binational Toxics Strategy) PBTs | |
| Persistent, bioaccumulative in wildlife | EPA PBTs - Waste Minimization Program (RCRA) | |
| show more | ||
| type of concern | product conditions | reference |
| Allowed workplace exposures restricted to very low doses | RTECS®- TLV/BEI,2006 | |
| Allowed workplace exposures restricted to low doses | European Union - Classification & Labelling | |
| Strong evidence of occupational hazards | European Union - Classification & Labelling |
| type of concern | product conditions | reference |
| Limited evidence of endocrine disruption | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Cancer - limited evidence | CHE Toxicant and Disease Database | |
| show more | ||
| type of concern | product conditions | reference |
| Cancer - moderate evidence - immune system | CHE Toxicant and Disease Database |
| type of concern | product conditions | reference |
| One or more animal studies show skin irritation at very low doses | RTECS®- American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society (Philadelphia, PA : W 2002 |
| type of concern | product conditions | reference |
| Wildlife and environmental toxicity | European Union - Classification & Labelling | |
| show more | ||
| type of concern | product conditions | reference |
| Occupational hazards related to handling | European Union - Classification & Labelling |
| type of concern | product conditions | reference |
| Not assessed for safety in cosmetics by industry panel | ||
| Insufficient data to determine safety | EPA Integrated Risk Information System (IRIS) | |
| 37,677 studies in PubMed science library may include information on the toxicity of this chemical see search results -> | PubMed |
| government/industry list/academic study | appears on list as | classification(s) |
| European Union - Classification & Labelling | MERCURY | •May be toxic to the reproductive system •Very toxic to aquatic organisms |
| European Union - Classification & Labelling | MERCURY DIFULMINATE | •Explosive •Extreme risk of explosion by shock, friction, fire or other sources of ignition •Toxic •Toxic by inhalation, skin contact, and ingestion •Danger of cumulative effects •Dangerous for the environment •Very toxic to aquatic organisms |
| European Union - Classification & Labelling | MERCURY DICHLORIDE; MERCURIC CHLORIDE | •Limited evidence of mutagenic effect •Very toxic to aquatic organisms |
| U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | MERCURY COMPOUNDS | •Restricted for use in cosmetics by the FDA (US) |
| Canada - Prohibited and Restricted Cosmetics Ingredients | MERCURY | •Use is restricted in Canadian cosmetics |
| Canada - Prohibited and Restricted Cosmetics Ingredients | THIMEROSAL | •Use is restricted in Canadian cosmetics |
| Canada - Prohibited and Restricted Cosmetics Ingredients | THIMEROSAL | •Prohibited from use in Canadian cosmetics |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: renal system toxicity; Condition: acute tubular necrosis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | ALS (Lou Gehrig's disease) - Limited |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: altered sex ratio; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: hematologic system toxicity; Condition: anemia (including hemolytic); Organs/tissues affected: blood |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: hematologic system toxicity; Condition: aplastic anemia; Organs/tissues affected: bone marrow |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: immune system toxicity; Condition: autoimmune antibodies (positive ANA, anti-DNA, RF, etc.); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: behavioral problems; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: nervous system toxicity; Condition: brain cancer (adult); Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: respiratory system toxicity; Condition: bronchitis - acute; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: cerebral palsy; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: renal system toxicity; Condition: chronic renal disease; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity, developmental toxicity; Condition: cognitive impairment (includes impaired learning, impaired memory, and decreased attention span)/mental retardation/developmental delay; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: congenital malformations (birth defects); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: skin toxicity; Condition: contact dermatitis - irritant; Organs/tissues affected: skin |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: cardiovascular system toxicity; Condition: coronary artery disease, peripheral vascular disease, atherosclerosis; Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: musculoskeletal system toxicity, developmental toxicity; Condition: cranio- facial malformations; Organs/tissues affected: bone |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: decreased coordination/ dysequilibrium; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | Decreased vision (includes blindness, retinopathy, optic neuropathy) - Good |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: delayed growth; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: erectile dysfunction; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: fetotoxicity (miscarriage/spontaneous abortion, stillbirth); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: renal system toxicity; Condition: glomerulonephritis; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: sense organ system toxicity; Condition: hearing loss; Organs/tissues affected: ears |
| CHE Toxicant and Disease Database | MERCURY | Hormonal changes (levels of circulating sex hormones - FSH/LH, Inhibin, and/or estrogens, progesterones, androgens) - Limited |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: cardiovascular system toxicity; Condition: hypertension (high blood pressure); Organs/tissues affected: blood vessels |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: immune system toxicity; Condition: immune suppression; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: developmental toxicity; Condition: low birth weight/small for gestational age/intra-uterine growth retardation; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: reproductive system toxicity; Condition: menstrual disorders (abnormal bleeding, short cycles, long cycles, irregular cycles, painful periods); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: Minamata disease; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: cardiovascular system toxicity; Condition: myocardial infarction (heart attack); Organs/tissues affected: heart |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: renal system toxicity; Condition: nephrotic syndrome; Organs/tissues affected: kidney |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: nervous system toxicity, developmental toxicity; Condition: neural tube defects/central nervous system malformations; Organs/tissues affected: neural tube |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: nervous system; Condition: neurosthenia (organic affective syndrome); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: peripheral neuropathy; Organs/tissues affected: peripheral nervous system |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: respiratory system toxicity; Condition: pneumonia; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: respiratory system toxicity; Condition: pneumonitis (hypersensitivity); Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: psychiatric disturbances (disorientation, hallucinations, psychosis, delirium, paranoias, anxiety/depression, emotional laibility, mood changes, euphoria).; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Moderate evidence in humans: respiratory system toxicity, cardiovascular system toxicity; Condition: pulmonary edema; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: respiratory system toxicity; Condition: pulmonary fibrosis; Organs/tissues affected: lungs |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: reduced fertility - female (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: reproductive system toxicity; Condition: reduced fertility - male (infertility and subfertility); Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: musculoskeletal system toxicity, skin toxicity; Condition: scleroderma; Organs/tissues affected: skin, connective tissue |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: seizures; Organs/tissues affected: brain |
| CHE Toxicant and Disease Database | MERCURY | •Strong evidence in humans: nervous system toxicity; Condition: spasticity/myoclonus; Organs/tissues affected: |
| CHE Toxicant and Disease Database | MERCURY | •Limited evidence in humans: endocrine system toxicity; Condition: thyroid disorders - hypothyroidism; Organs/tissues affected: thyroid gland |
| EPA Clean Water Act - Priority Pollutants | MERCURY | •Priority water pollutant under the Clean Water Act |
| Environmental Canada Domestic Substance List | MERCURATE(1-), ETHYL[2-MERCAPTOBENZOATO(2-)-O,S]-, SODIUM | •This chemical was flagged for further attention by CEPA due to suspected aquatic toxicity and persistence. |
| Illinois EPA Chemicals Associated with Endocrine System | MERCURY | •EPA: probable endocrine disruptor |
| EPA Integrated Risk Information System (IRIS) | MERCURY, ELEMENTAL | •Group D: Not classifiable as to human carcinogenicity (EPA classification) |
| European Union - Banned or Restricted in Cosmetics | MERCURY AND ITS COMPOUNDS | •Restricted in EU cosmetics (mandatory manufacturing or structural specifications) |
| European Union - Water Framework Directive | MERCURY AND ITS COMPOUNDS | •Priority substance in EU water policy |
| EPA Hazardous Air Pollutants | MERCURY COMPOUNDS | •Hazardous air pollutant under Clean Air Act |
| National Library of Medicine HazMap | MERCURY | •Skin Designation (ACGIH) - Danger of cutaneous absorption (ACGIH): Yes; •Skin Sensitizer - An agent that can induce an allergic reaction in the skin or lungs: Yes; •Reproductive Toxin - A chemical that is toxic to the reproductive system, including defects in the progeny and injury to male and female reproductive function: Yes; •Restricted - Regulations that have banned or restricted the use of the agent: Paint manufacturers agreed to discontinued the use of mercury in exterior paints after September 1991 and in interior paints after Aug 20, 1990. [ATSDR Case Studies # 17, p. 3]; •Toxic Pneumonitis: Yes; •Nephrotoxin: Yes; •Neurotoxin: Sensorimotor Neuropathy;LC: 11 |
| National Library of Medicine HazMap | THIMEROSAL | •Skin Designation (ACGIH) - Danger of cutaneous absorption (ACGIH): Yes; •Skin Sensitizer - An agent that can induce an allergic reaction in the skin or lungs: Yes; •TLV (ACGIH) - Threshold limit value (ACGIH): 0.1 mg/m3, as Hg; •BEI - Biological Exposure Indices (American Conference of Governmental Industrial Hygiene, ACGIH): Total inorganic Hg in urine = 35 ug/g creatinine, sample preshift; Total inorganic Hg in blood = 15 ug/L, sample at end of shift at end of workweek; |
| National Library of Medicine HazMap | MERCURY, ARYL COMPOUNDS | •Skin Designation (ACGIH) - Danger of cutaneous absorption (ACGIH): Yes; •Reproductive Toxin - A chemical that is toxic to the reproductive system, including defects in the progeny and injury to male and female reproductive function: Yes; •Restricted - Regulations that have banned or restricted the use of the agent: EPA banned for pesticide use phenylmercuric acetate (PMA), phenylmercuric oleate (PMO), and Di(phenylmercury)dodecyenylsuccinate (PMDS); [http://www.epa.gov/oppfead1/international/piclist.htm]; •Neurotoxin: Other CNS Neurotoxin; •Bioaccumulates: Yes;TL: 0.1 m |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | MERCURY AND INORGANIC MERCURY COMPOUNDS | •IARC Group 3 (no cancer link) |
| Chemicals known to be neurotoxic to humans | MERCURY | •Known to be neurotoxic to humans, suspected developmental neurotoxin |
| Our Stolen Future Endocrine Disruptors | MERCURY | • |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | MERCURY COMPOUNDS | •Persistent toxicant under Canada's Accelerated Reduction/Elimination of Toxics program - targeted for elimination or reduction |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | MERCURY COMPOUNDS | •Persistent, bioaccumulative toxicant - Great Lakes Binational Strategy, Tier 1 concern (highest), targeted for phase-out |
| EPA PBTs - Waste Minimization Program (RCRA) | MERCURY | •Persistent, bioaccumulative toxicant - Resource Conservation and Recovery Act, priority chemical for voluntary waste/emission reductions |
| EPA Toxic Release Inventory PBTs | MERCURY COMPOUNDS | •Very persistent and bioaccumulative toxicant - targeted for waste reporting under U.S. Environmental Protection Agency Toxics Release Inventory programs |
| National Academy - Institute of Medicine, 2004 | THIMEROSAL | Thimerosal vaccines are causally associated with autism |
| National Academy - Institute of Medicine, 2004 | THIMEROSAL | Thimerosal vaccines are causally associated with autism in children |
| California EPA Proposition 65 | MERCURY AND MERCURY COMPOUNDS | •Developmental toxin: California Proposition 65 |
| US EPA, 9204 | MERCURY | •Reproductive toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1996 | MERCURY | •Kidney toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1996 | MERCURY | •Skin or sense organ toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1990 | MERCURY | •Respiratory toxicity hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 1987 | MERCURY | •Immunotoxicity hazards: suspected |
| Illinois EPA, 1997 | MERCURY | •Endocrine toxicity hazards: suspected |
| Klaassen, C, 1996 | MERCURY | •Cardiovascular or blood toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | MERCURY | •Developmental toxicity hazards: recognized |
| National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances, 1995 | MERCURY | •Gastrointestinal or liver toxicity hazards: suspected |
| Malachowsky, M, 1995 | MERCURY COMPOUNDS | •Cardiovascular or blood toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | MERCURY COMPOUNDS | •Developmental toxicity hazards: recognized |
| Proposition 65 List of Carcinogens | MERCURY COMPOUNDS | •Cancer hazards: suspected |
| RTECS®- TLV/BEI,2006 | THIMEROSAL | • occupationally related - ACGIH TLV (human TWA) |
| RTECS®- "Chemistry of Pesticides," Melnikov, N 1971 | THIMEROSAL | • broad systemic - Broad systemic toxicity (rat LD50) |
| RTECS®- American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society (Philadelphia, PA : W 2002 | THIMEROSAL | • skin - Dermatitis, allergic ( human TDLo) |
| RTECS®- American Journal of Ophthalmology 1974 | THIMEROSAL | • sense organ - Primary eye irritant (rabbit ) |
| RTECS®- American Journal of Ophthalmology 1974 | THIMEROSAL | • sense organ - Primary eye irritant (rabbit ) |
| RTECS®- Archives of Ophthalmology (Chicago) 1975 | THIMEROSAL | • reproductive - Abortion (rat TDLo) • reproductive - Fetal death (rabbit TDLo) • reproductive - Post-implantation mortality (rat TDLo) |
| RTECS®- Archives of Toxicology 2003 | THIMEROSAL | • mutagenic - Positive mutation assay: Micronucleus test ( human lym) |
| RTECS®- Archives of Toxicology 2003 | THIMEROSAL | • mutagenic - Positive mutation assay: Micronucleus test ( human lym) |
| RTECS®- Clinical Toxicology 1971 | THIMEROSAL | • metabolic - Weight loss or decreased weight gain (rat TDLo) • respiratory - Fibrosis, focal (pneumoconiosis) (rat TDLo) |
| RTECS®- Clinical Toxicology 1971 | THIMEROSAL | • broad systemic - Broad systemic toxicity (rat LD50) • cancer - reproductive neoplasms (rat TDLo) • cancer - Tumors at site of application (rat TDLo) |
| RTECS®- Environmental and Molecular Mutagenesis 1992 | THIMEROSAL | • mutagenic - Positive mutation assay: Micronucleus test (mouse ipr) • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (mouse ipr) |
| RTECS®- Environmental and Molecular Mutagenesis 1992 | THIMEROSAL | • mutagenic - Positive mutation assay: Micronucleus test (mouse ipr) • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (mouse ipr) |
| RTECS®- Journal of Pediatrics 1984 | THIMEROSAL | • brain and nervous system - Ataxia (child LDLo) • metabolic - Metabolic acidosis (child LDLo) • gastrointestinal - Nausea or vomiting (child LDLo) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (hamster lng) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: other mutation test systems (hamster emb) • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (hamster emb) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction ( human lym) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: Micronucleus test (hamster lng) |
| RTECS®- Mutation Research 2003 | THIMEROSAL | • mutagenic - Positive mutation assay: DNA Damage (hamster ovr) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (hamster lng) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: other mutation test systems (hamster emb) • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction (hamster emb) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: Sex Chromosome Loss and Nondisjunction ( human lym) |
| RTECS®- Mutation Research 1993 | THIMEROSAL | • mutagenic - Positive mutation assay: Micronucleus test (hamster lng) |
| RTECS®- Mutation Research 2003 | THIMEROSAL | • mutagenic - Positive mutation assay: DNA Damage (hamster ovr) |
| RTECS®- Nippon Yakurigaku Zasshi 1962 | THIMEROSAL | • broad systemic - Broad systemic toxicity (mouse LD50) |
| RTECS®- Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc 1966 | THIMEROSAL | • broad systemic - Broad systemic toxicity (rat LD50) |
| RTECS®- Quarterly Journal of Pharmacy & Pharmacology 1939 | THIMEROSAL | • broad systemic - Broad systemic toxicity (mouse LD50) • kidney or renal system - Changes in tubules (including acute renal failure, acute tubular (mouse LD50) |
| RTECS®- Rinsho Ganka 1972 | THIMEROSAL | • reproductive - Fetal death (rabbit TDLo) |
| RTECS®- Toxicologist | THIMEROSAL | • blood - Other changes (mouse TDLo) • brain and nervous system - Other degenerative changes (mouse TDLo) • metabolic - Other metals (mouse TDLo) |
| government/industry list/academic study | reference |
| European Union - Classification & Labelling | CPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex VI of Directive 67/548/EEC through the 31st ATP. |
| U.S. - Ingredients Prohibited and Restricted in Cosmetics by FDA Regulations | FDA (U.S. Food and Drug Administration), 2006. Ingredients Prohibited and Restricted by FDA Regulations. FDA Center for Food Safety and Applied Nutrition, Office of Cosmetics and Colors. Downloaded from http://www.cfsan.fda.gov/~dms/cos-210.html. |
| Canada - Prohibited and Restricted Cosmetics Ingredients | Health Canada. 2007. List of Prohibited and Restricted Cosmetic Ingredients. Canada's Cosmetic Ingredient Hotlist. March 2007. |
| CHE Toxicant and Disease Database | CHE (The Collaborative on Health and the Environment). 2006. Toxicant and Disease Database. |
| EPA Clean Water Act - Priority Pollutants | |
| Environmental Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. |
| EPA Integrated Risk Information System (IRIS) | EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines. |
| European Union - Banned or Restricted in Cosmetics | EC (European Commission of the European Union). 1999-2006. Enterprise Directorate-General Pharmaceuticals and Cosmetics. The rules governing cosmetic products in the European Union, Volume 1, "Cosmetics legislation." |
| European Union - Water Framework Directive | EU (European Union). 2000. Water Framework Directive (Directive 2000/60/EC ) - integrated river basin management for Europe. List of priority substances. |
| EPA Hazardous Air Pollutants | EPA (U.S. Environmental Protection Agency). 2005. Office of Air. The 112(b)1 Hazardous Air Pollutants List (as modified). Last modified: 12 Dec 2005. |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| Chemicals known to be neurotoxic to humans | Grandjean P and PJ Landrigan. 2006. Developmental neurotoxicity of industrial chemicals. Lancet. 2006 Dec 16;368(9553):2167-78. |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | EC (Environment Canada). 1994. Accelerated Reduction/Elimination of Toxics (ARET). ARET substance list of persistent, bioaccumulative and toxic chemicals. |
| Great Lakes BTS (Binational Toxics Strategy) PBTs | Great Lakes BTS (Binational Toxics Strategy). 1997. Canada-United States Strategy for the Virtual Elimination of Persistent Toxic Substances in the Great Lakes. Appendix I - Level 1 and Level 2 substances. |
| EPA PBTs - Waste Minimization Program (RCRA) | EPA (U.S. Environmental Protection Agency). 1998. Resource Conservatin and Recovery Act (RCRA) Waste Minimization Program - priority chemicals for elimination or reduction. |
| EPA Toxic Release Inventory PBTs | EPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule. |
| Open scientific literature | National Academy - Institute of Medicine, 2004. "Immunization Safety Review", Accessed at http://www.iom.edu/?id=4705 on May 14, 2007. |
| Open scientific literature | National Academy - Institute of Medicine, 2004. "Immunization Safety Review", Accessed at http://www.iom.edu/?id=4705 on May 14, 2007. |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. |
| Scorecard.org Toxicity Information | US EPA. Roadmaps to Sources of Information on Chemicals Listed in the Emergency Planning Community and Community Right-to-Know Act (Also Known as SARA Title 3), Section 313 Toxic Release Inventory (for Microcomputers). (Report Number EPADFDK92040). 1991. Data file distributed in 2 diskettes by Office of Pollution, Prevention, and Toxics, Environmental Protection Agency, Washington, DC. NOTE: Datasource no longer being maintained by EPA; not currently available online., Frazier , L. and M. L. Hage (eds.). Reproductive Hazards of the Workplace, Wiley Europe, 1998. Table 10 (Partial List of Reproductive Toxicants) available at http://www.pharmacy.ohio-state.edu/homepage/safety/chemhygiene_table_repro.pdf., A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, California EPA, Office of Environmental Health Hazard Assessment. Acute Reference Exposure Levels (RELs), Averaging Times, and Toxicologic Endpoints. Includes all Acute Reference Exposure Levels (ARELs) developed by OEHHA through May 2000http://www.oehha.org/air/acute_rels/allAcRELs.html |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., Landrigan, P.J., Goyer, R.A. Clarkson, T.W., Sandler, D.P., Smith, J.H., Thun, M.J., and R. Wedeen. The Work-Relatedness of Renal Disease. Archives of Environmental Health. 39(3): 225-230. 1984. (Table 2: Estimated Numbers of Workers in the United States with Potential Occupational Exposures to Known or Suspect Nephrotoxins)., Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm, Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation. |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Swedish National Chemicals Inspectorate. Labelling of chemical products, Swedish regulations and general advice with regard to the classification and labelling of chemical products hazardous to health, flammables and explosives. List of Allergenic Substances. National Chemicals Inspectorate, Solna, Sweden. 1987, 1990-1992. |
| Scorecard.org Toxicity Information | Illinois EPA. Endocrine Disruptors Strategy. 1997. (Table 1: Preliminary List of Chemicals Associated with Endocrine System Effects in Animals and Humans or In Vitro). http://www.nihs.go.jp/hse/environ/illiepatable.htm, Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| Scorecard.org Toxicity Information | National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html. |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| RTECS®- TLV/BEI,2006 | RTECS®- TLV/BEI,2006 |
| RTECS®- "Chemistry of Pesticides," Melnikov, N 1971 | RTECS®- "Chemistry of Pesticides," Melnikov, N.N., New York, Springer-Verlag New York, Inc., 1971 -,290,1971 |
| RTECS®- American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society (Philadelphia, PA : W 2002 | RTECS®- American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society (Philadelphia, PA : W.B. Saunders, Harcourt Brace Jovanovich) V.1-14 1990-2003. 13,3,2002 |
| RTECS®- American Journal of Ophthalmology 1974 | RTECS®- American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 1918- 78,98,1974 |
| RTECS®- American Journal of Ophthalmology 1974 | RTECS®- American Journal of Ophthalmology. (Ophthalmic Pub. Co., 435 N. Michigan Ave., Suite 1415, Chicago, IL 60611) Series 3: V.1- 78,98,1974 |
| RTECS®- Archives of Ophthalmology (Chicago) 1975 | RTECS®- Archives of Ophthalmology (Chicago). (AMA, 535 N. Dearborn St., Chicago, IL 60610) New series: V.1-44(3), 1929-50; V.64- 1960- 93,52,1975 |
| RTECS®- Archives of Toxicology 2003 | RTECS®- Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- 77,50,2003 |
| RTECS®- Archives of Toxicology 2003 | RTECS®- Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 77,50,2003 |
| RTECS®- Clinical Toxicology 1971 | RTECS®- Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. 4(2),185,1971 |
| RTECS®- Clinical Toxicology 1971 | RTECS®- Clinical Toxicology. (New York, NY) V.1-18, 1968-81. For publisher information, see JTCTDW. 4,185,1971 |
| RTECS®- Environmental and Molecular Mutagenesis 1992 | RTECS®- Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- 20,106,1992 |
| RTECS®- Environmental and Molecular Mutagenesis 1992 | RTECS®- Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 20,106,1992 |
| RTECS®- Journal of Pediatrics 1984 | RTECS®- Journal of Pediatrics. (C.V. Mosby Co., 11830 Westline Industrial Dr., St. Louis, MO 63141) V.1- 1932- 104,311,1984 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 287,29,1993 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 287,47,1993 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 287,57,1993 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 287,71,1993 |
| RTECS®- Mutation Research 2003 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 537,151,2003 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 287,29,1993 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 287,47,1993 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 287,57,1993 |
| RTECS®- Mutation Research 1993 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 287,71,1993 |
| RTECS®- Mutation Research 2003 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 537,151,2003 |
| RTECS®- Nippon Yakurigaku Zasshi 1962 | RTECS®- Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- -1944 58,235,1962 |
| RTECS®- Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc 1966 | RTECS®- Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. (Topeka, KS) -,1130,1966 |
| RTECS®- Quarterly Journal of Pharmacy & Pharmacology 1939 | RTECS®- Quarterly Journal of Pharmacy & Pharmacology. (London, UK) V.2-21, 1929-48. For publisher information, see JPPMAB. 12,212,1939 |
| RTECS®- Rinsho Ganka 1972 | RTECS®- Rinsho Ganka. Clinical Ophthalmology. (Igaku Shoin, 5-24-3 Hongo, Bunkyo-ku, Tokyo 113-91, Japan) V.1- 1947- 26,631,1972 |
| RTECS®- Toxicologist | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72(Suppl |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.
No items in basket.
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
It's true. EWG's researchers list the products and ingredients you should avoid in What Not to Buy.